Stites S D, Cooblall C A, Aronovitz J, Singletary S B, Micklow K, Sjeime M
Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Scientific and Health Policy Initiatives, International Society for Pharmacoeconomics and Outcomes Research, Lawrenceville, NJ, USA.
J Hosp Infect. 2016 Nov;94(3):242-248. doi: 10.1016/j.jhin.2016.07.022. Epub 2016 Aug 24.
The incidence and severity of Clostridium difficile infection (CDI) have increased in recent years. Predictive models may help to identify at-risk patients before the onset of infection. Early identification of high-risk patients could help antimicrobial stewardship (AMS) programmes and other initiatives to better prevent C. difficile in these patients.
To develop a predictive model that identifies patients at high risk for CDI at the time of hospitalization. This approach to early identification was evaluated to determine if it could improve upon a pre-existing AMS programme.
Logistic regression and receiver operating characteristic (ROC) curve analyses were used to develop an analytic model to predict risk for CDI at the time of hospitalization in a retrospective cohort of inpatients. The model was validated in a prospective cohort. Concurrence between the model's risk predictions and a pre-existing AMS programme was assessed.
The model identified 55% of patients who later tested positive as being at high risk for CDI at the time of admission. One in every 32 high-risk patients with potentially modifiable antimicrobial risk factors tested positive for CDI. Half (53%) tested positive before meeting the risk criteria for the hospital's AMS programme.
Analytic models can identify most patients prospectively at the time of admission who later test positive for C. difficile. This approach to early identification may help AMS programmes to pursue susceptibility testing and modifications to antimicrobial therapies at an earlier stage in order to better prevent CDI.
近年来,艰难梭菌感染(CDI)的发病率和严重程度有所增加。预测模型可能有助于在感染发作前识别高危患者。早期识别高危患者有助于抗菌药物管理(AMS)计划和其他举措更好地预防这些患者发生艰难梭菌感染。
开发一种预测模型,以识别住院时发生CDI的高危患者。对这种早期识别方法进行评估,以确定其是否能在现有的AMS计划基础上有所改进。
采用逻辑回归和受试者工作特征(ROC)曲线分析,在一个回顾性住院患者队列中开发一个分析模型,以预测住院时发生CDI的风险。该模型在前瞻性队列中进行验证。评估模型的风险预测与现有的AMS计划之间的一致性。
该模型识别出55%后来检测呈阳性的患者在入院时为CDI高危患者。每32名具有潜在可改变抗菌风险因素的高危患者中就有1人CDI检测呈阳性。其中一半(53%)在达到医院AMS计划的风险标准之前就检测呈阳性。
分析模型可以前瞻性地识别出大多数后来艰难梭菌检测呈阳性的入院患者。这种早期识别方法可能有助于AMS计划在更早阶段进行药敏试验和调整抗菌治疗方案,以便更好地预防CDI。